Hyseq, Variagenics To Merge In $55.9M Stock Transaction

It has been a year of downsizing and restructuring, and the long list of companies that have done so include Hyseq Pharmaceuticals Inc. and Variagenics Inc. Those two slimmed-down companies - one focused on drug discovery and one on diagnostics - said Monday they were merging in a stock deal valued at about $56 million. (BioWorld Today)